Manuel Martinez Domingo

Lic. Manuel Martinez Domingo is currently President and CEO of Laboratorios Grupo Columbia of Mexico. Laboratorios Columbia Group is a private pharmaceutical company that manufactures and sells pharmaceutical products for diabetes, obesity, oncology, infectious diseases, and inflammatory diseases.

He managed and successfully grew the Columbia Group from 200 employees to 2800 employees with subsidiaries in Canada, Finland, Denmark, Portugal, Spain, the United Kingdom and Argentina, generating an excess of $300 M annually.

Lic. Manuel M. Domingo has 48 years of executive and managerial leadership experience, in Sandoz, American Cyanamid, Searle Mexico, Laboratorio Columbia, and Grupo Columbia.

During his career, he held many board positions including in the Entrepreneurial Latin American Foundation, Ibero-American University, Florida International University, Hospital Medica Sur, Dr. Manuel Gea Gonzalez Hospital and was a member of the Chamber of International Commerce in the United Nations among other prestigious positions.

He earned an MBA with a specialty in Finance and Economics from the Monterrey Technology Institute in Mexico, and a Master's degree in Management from Universidad National Autonoma de Mexico.